Published in Hospital Law Weekly, February 14th, 2008
"The FDA should be encouraging innovative companies to introduce their science-based devices to facilitate transfer of the molecular technologies developed in the past 15 years to clinical laboratories to improve patient care," said Sin Hang Lee, MD, of HiFi DNA Tech, based in Trumbull, Conn.
"Changing the classification encourages innovative...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hospital Law Weekly